Supriya Lifescience IPO Subscription Status
Supriya Lifescience IPO was subscribed 73.94 times when bidding closed on 20 Dec 2021: QIB 32.91x, NII 166.69x, Retail 57.91x.
The Supriya Lifescience IPO has been subscribed 73.94x times overall. Retail investors have shown interest with bids for 57.91x the shares available. The Non-Institutional Investor (NII) category has been subscribed 166.69x. Qualified Institutional Buyers (QIBs) have subscribed 32.91x. Data last updated on 10 Nov, 07:27 AM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 16 Dec, 2021 and closes on 20 Dec, 2021. The shares are expected to list on stock exchanges on 28 Dec, 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 32.91x |
| NII | - of - - | 166.69x |
| Retail | - of - - | 57.91x |
| TOTAL | - - | 73.94x |
Supriya Lifescience IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 58 applicants will be successful.
Market Sentiment
Strong grey market premium of 91% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 32.91x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
20 Dec 2021
Day 3 |
73.94x | ▼ | |
|
QIB32.91x
BHNI-
SHNI-
Retail57.91x
|
|||
|
17 Dec 2021
Day 2 |
5.7x | ▼ | |
|
QIB0.53x
BHNI-
SHNI-
Retail25.37x
|
|||
|
16 Dec 2021
Day 1 |
2.33x | ▼ | |
|
QIB-
BHNI-
SHNI-
Retail11.84x
|
|||
Supriya Lifescience IPO dates
From the bidding window to listing. Today is 11 November.
- Open 16 Dec 2021
- Close 20 Dec 2021
- Allotment 23 Dec 2021
- Refund/credit 24 Dec 2021
- Listing 28 Dec 2021
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Supriya Lifescience IPO?
As of IPO close date (20 Dec, 2021), the Supriya Lifescience IPO is subscribed 73.94x times. Retail category is 57.91x, and NII is 166.69x subscribed.
When is the allotment date for Supriya Lifescience IPO?
The allotment for Supriya Lifescience IPO is expected to be finalized on 23 December, 2021.
What is the GMP of Supriya Lifescience?
The Grey Market Premium (GMP) for Supriya Lifescience is currently ₹250, indicating a potential listing gain of 91%.
When will Supriya Lifescience IPO list on the stock market?
Supriya Lifescience is scheduled to list on BSE and NSE on 28 December, 2021.
What are the chances of getting allotment in Supriya Lifescience IPO?
The retail category is oversubscribed at 57.91x, meaning allotment is by lottery. Statistically, approximately 1 in 58 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 32.91x mean for Supriya Lifescience IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 32.91x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Supriya Lifescience IPO allotment status?
After the allotment date (23 Dec, 2021), you can check your Supriya Lifescience IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Supriya Lifescience IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
